- PROCESS OF PREPARING TYROSINE KINASE INHIBITOR
-
The invention relates to a process for preparing sodium 4-((3-(4-cyclohexylpiperazin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzoate.
- -
-
Page/Page column 15
(2017/03/21)
-
- CRYSTALLINE FORMS OF TYROSINE KINASE INHIBITORS AND THEIR SALTS
-
The disclosure relates to various polymorphic forms and amorphous form of sodium 4-((3-(4-cyclohexylpiperazin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzoate, including the polymorphic form A, mixtures of the polymorphs, process for the preparation thereof and the use thereof in a pharmaceutical composition containing thereof.
- -
-
Page/Page column 27
(2016/04/09)
-
- COMPOSITIONS OF COMPOUNDS AND USES THEREOF
-
The present disclosure relates to novel synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same. The disclosure further concerns the use of such compounds in the treatment and/or prevention of certain types of cancers, pain, inflammation, restenosis, atherosclerosis, psoriasis, thrombosis, Alzheimer's, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination.
- -
-
Paragraph 0199; 0206
(2015/09/22)
-